Press release
Switzerland’s Basel Region Crowned ‘Europe’s Top Destination to Launch a Drug Device Company’, According to Pharmapack Report
January 14, 2025Switzerland, pharmapack, report
 Pharmapack Europe: ‘Basel the best location for drug device innovation in Europe thanks to combination of world class manufacturing and …
NICE recommendation for KORSERDU®▼ (elacestrant) marks ‘step-change’ in the treatment of ESR1-mutated metastatic breast cancer
December 19, 2024ESR1, Menari Group, NICE, breast cancer, drug
Elacestrant is the first tailored treatment for certain people with oestrogen receptor (ER)-positive HER2-negative locally advanced and metastatic breast cancer …
MHRA Grants Marketing Authorisation for LEO Pharma’s Anzupgo® ▼(delgocitinib) cream in Great Britain
December 16, 2024LEO Pharma, eczema
The Medicines and Healthcare Products Regulatory Agency (MHRA) has granted marketing authorisation in Great Britain for Anzupgo® (delgocitinib) 20mg/g cream …
Pharma prepares for CDMO growth in 2025 as CPHI Milan reports record attendance
December 13, 2024CPHI Milan, CPhI, networking
13 December 2024 – Amsterdam, the Netherlands –  CPHI Milan – the world’s largest pharma event – hosted last month …
Deep Science Ventures and General Inception collaborate to create fibrosis-focused therapeutics company
December 12, 2024Corporate, Deep Science Ventures, General Inception, fibrosis, venture
12 December 2024 – London, UK, and Palo Alto, CA, US – Deep Science Ventures, a UK-based venture studio, and …
NICE RECOMMENDS LILLY’S TIRZEPATIDE (MOUNJARO ®▼) FOR MANAGING OVERWEIGHT AND OBESITY IN FINAL DRAFT GUIDANCE
December 10, 2024Mounjaro, NICE, lilly, weight-loss
BASINGSTOKE, 5th December 2024 – Eli Lilly and Company announced today that the National Institute for Health and Care Excellence …
Ceryx Medical Initiates First-In-Human Study of the Cysoniâ„¢ RSA Pacemaker
November 21, 2024Ceryx Medical, Devices, biotech
Ceryx’s Cysoni pacing technology is designed to provide superior therapeutic outcomes for Heart Failure patients by improving cardiac output using …
Glox Therapeutics Awarded £1M PACE Grant to Accelerate Development of Precision Antibiotics Against Antimicrobial-resistant Pathogens
November 20, 2024AMR Week, Glox Therapeutics, antimicrobial resistance
Novel therapeutics to address unmet clinical need for pneumonias caused by drug-resistant Escherichia coli and Klebsiella pneumoniae PACE provides funding …
Great Place To Work® and Fortune Name Chiesi Group No. 23in 2024 World’s Best Workplaces™ List
November 19, 2024Chiesi, Corporate, best workplace
Chiesi is the only European pharmaceutical company and the first Italian company ever to be included in the World’s Best …
Barinthus Bio Announces Results From Ongoing Phase 2b Chronic Hepatitis B Trial, Including Achievement of Functional Cure and HBsAb Seroconversion
November 18, 2024barinthius Bio
Eight participants achieved HBsAg loss at any time. Two participants met criteria for functional cure. Two participants who discontinued NUC …
CMS commences formal review for Topical Oxygen Therapy coverage
November 11, 2024Wound Healing, topical oxygen therapy, wound care
11 November 2024 AOTI, INC. (AIM: AOTI), a medical technology group focussed on the durable healing of wounds and prevention …
NorthWest EHealth (NWEH) announces a pilot to test a new model for finding and recruiting participants for clinical trials using the Clinical Practice Research Datalink
November 5, 2024Research and Development NorthWest Ehealth, clinical trials
The pilot aims to speed up the process for safely and securely finding participants for UK clinical trials, improving efficiencies …
FlyPharma Vienna 2024: An Event to Remember!
November 4, 2024Corporate, FlyPharma 2024, Samedan, event
Samedan announces that their 2024 FlyPharma Conference, held in Office Park 4, Vienna AirportCity, Austria, has officially concluded! As a …
Valneva Scotland supports local cancer charity Team Jak FoundationÂ
October 31, 2024Support Services Oncology, Scotland, Valneva Scotland, cancer charity, paediarics, vaccines
Valneva Scotland, the country’s largest vaccine producer, has partnered with local West Lothian-headquartered charity, Team Jak, helping towards the organisation’s …
From molecule to market and beyond: Uniphar announces extended global commercialization platform
October 25, 2024CRO, UniPhar, cell and gene
22 October 2024 – Dublin, Ireland – Healthcare services business, Uniphar, has developed its full-service offering that harnesses Uniphar’s 55 …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
